These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Molecular identification and antifungal susceptibility profiles of Candida dubliniensis and Candida africana isolated from vulvovaginal candidiasis: A single-centre experience in Iran. Shokoohi G; Javidnia J; Mirhendi H; Rasekh-Jahromi A; Rezaei-Matehkolaei A; Ansari S; Maryami F; Goodarzi S; Romeo O Mycoses; 2021 Jul; 64(7):771-779. PubMed ID: 33811780 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of Candida albicans-closely related yeasts, Candida africana and Candida dubliniensis, in vulvovaginal candidiasis. Shan Y; Fan S; Liu X; Li J Med Mycol; 2014 Aug; 52(6):636-40. PubMed ID: 25023482 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of Candida africana and Candida dubliniensis, in vulvovaginal candidiasis: First Turkish Candida africana isolates from vulvovaginal candidiasis. Hazirolan G; Altun HU; Gumral R; Gursoy NC; Otlu B; Sancak B J Mycol Med; 2017 Sep; 27(3):376-381. PubMed ID: 28641919 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argentina. Theill L; Dudiuk C; Morano S; Gamarra S; Nardin ME; Méndez E; Garcia-Effron G Rev Argent Microbiol; 2016; 48(1):43-9. PubMed ID: 26922471 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of Candida albicans, Candida dubliniensis and Candida africana in pregnant women suffering from vulvovaginal candidiasis in Argentina. Mucci MJ; Cuestas ML; Landanburu MF; Mujica MT Rev Iberoam Micol; 2017; 34(2):72-76. PubMed ID: 28385421 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates. Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology, antifungal susceptibility, and pathogenicity of Candida africana isolates from the United Kingdom. Borman AM; Szekely A; Linton CJ; Palmer MD; Brown P; Johnson EM J Clin Microbiol; 2013 Mar; 51(3):967-72. PubMed ID: 23303503 [TBL] [Abstract][Full Text] [Related]
9. Molecular Characterization of Highly Susceptible Candida africana from Vulvovaginal Candidiasis. Yazdanparast SA; Khodavaisy S; Fakhim H; Shokohi T; Haghani I; Nabili M; Gholami H; Ahmadi I; Badali H Mycopathologia; 2015 Dec; 180(5-6):317-23. PubMed ID: 26183965 [TBL] [Abstract][Full Text] [Related]
11. Multilocus sequence typing of Candida africana from patients with vulvovaginal candidiasis in New Delhi, India. Sharma C; Muralidhar S; Xu J; Meis JF; Chowdhary A Mycoses; 2014 Sep; 57(9):544-52. PubMed ID: 24697839 [TBL] [Abstract][Full Text] [Related]
12. Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis. Shi Y; Zhu Y; Fan S; Liu X; Liang Y; Shan Y BMC Infect Dis; 2020 Apr; 20(1):287. PubMed ID: 32393342 [TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006. Fan SR; Liu XP; Li JW J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710 [TBL] [Abstract][Full Text] [Related]
14. Candida africana in recurrent vulvovaginal candidiasis (RVVC) patients: frequency and phenotypic and genotypic characteristics. Naeimi B; Mirhendi H; Khamisipour G; Sadeghzadeh F; Ahmadi B J Med Microbiol; 2018 Nov; 67(11):1601-1607. PubMed ID: 30248002 [TBL] [Abstract][Full Text] [Related]
15. Distribution, antifungal susceptibility pattern and intra-Candida albicans species complex prevalence of Candida africana: A systematic review and meta-analysis. Gharehbolagh SA; Fallah B; Izadi A; Ardestani ZS; Malekifar P; M Borman A; Mahmoudi S PLoS One; 2020; 15(8):e0237046. PubMed ID: 32817677 [TBL] [Abstract][Full Text] [Related]
16. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012. Liu XP; Fan SR; Peng YT; Zhang HP J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725 [TBL] [Abstract][Full Text] [Related]
17. Multilocus sequence typing analysis of Candida africana from vulvovaginal candidiasis. Zhu YX; Shi Y; Fan SR; Liu XP; Yang J; Zhong SL BMC Infect Dis; 2019 May; 19(1):461. PubMed ID: 31117966 [TBL] [Abstract][Full Text] [Related]
18. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. Richter SS; Galask RP; Messer SA; Hollis RJ; Diekema DJ; Pfaller MA J Clin Microbiol; 2005 May; 43(5):2155-62. PubMed ID: 15872235 [TBL] [Abstract][Full Text] [Related]
19. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis. Nagashima M; Yamagishi Y; Mikamo H J Infect Chemother; 2016 Feb; 22(2):124-6. PubMed ID: 26627336 [TBL] [Abstract][Full Text] [Related]
20. Epidemiology and antifungal susceptibilities of yeasts causing vulvovaginitis in a teaching hospital. Gamarra S; Morano S; Dudiuk C; Mancilla E; Nardin ME; de Los Angeles Méndez E; Garcia-Effron G Mycopathologia; 2014 Oct; 178(3-4):251-8. PubMed ID: 25005365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]